Explore All 191 Merger Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | May 13, 2016 |
| Target | WaferGen Bio-systems |
| Sector | Life Science |
| Buyer(s) | Takara Bio |
| Deal Type | Merger |
| Deal Value | 50M USD |
| Advisor(s) | Torreya Partners (Financial) K&L Gates (Legal) |
FILTER BY
| Category | Company |
|---|---|
| Founded | 2002 |
| Sector | Life Science |
| Employees | 1,779 |
| Revenue | 45.0B JPY (2025) |
Takara Bio is a biotechnology company that provides biotechnology research and development. Takara Bio active research and product development activities in the fields of gene and cell-based therapy and agricultural biotechnology; and is committed to preventing disease and improving the quality of life for all people through the use of biotechnology. Takara Bio was founded in 2002 and is based in Kusatsu, Japan.
| Deal Context for Buyer | # |
|---|---|
| Overall | 3 of 3 |
| Sector: Life Science | 2 of 2 |
| Type: Merger | 1 of 1 |
| State: California | 2 of 2 |
| Country: United States | 2 of 2 |
| Year: 2016 | 1 of 1 |
| Size (of disclosed) | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-07-29 |
Cellectis AB
Gothenburg, Sweden Cellectis AB is a biotechnology company focused on applications of human embryonic stem cell (HES) based products and technologies for the industry and the research community. |
Buy | - |
